News | July 08, 2010

TCT Surgeons Course Highlights Role of Hybrid Suites

The hybrid suite at the Texas Heart Hospital Baylor Plano, Texas.

July 8, 2010 – The annual Transcatheter Cardiovascular Therapeutics (TCT) event has traditionally been a symposium for interventional cardiologists. However, as an increasing number of hybrid intervention/minimally invasive surgical procedures bring surgeons into the arena of cath lab techniques, TCT started a course for surgeons who specialize in hybrid procedures. Now in its fourth year, the course will run during TCT, Sept. 21-25, 2010, in Washington, D.C.

“This meeting will drive forward the growing collaboration among interventional cardiologists and cardiac surgeons in the treatment of patients with structural and coronary artery disease,” said Mathew Williams, M.D., course director, and surgical director, Cardiovascular Transcatheter Therapies at New York-Presbyterian Hospital/Columbia University Medical Center. “The surgeon brings tremendous knowledge, a valuable skill set and a unique perspective to the interventional environment and the cross-trained surgeon is positioned ideally to make the most informed and unbiased treatment decision for patients with coronary and endovascular disease.”

One of the course highlights is an overview of hybrid coronary therapy, which involves a combination of traditional surgery along with the placement of coronary stents in patients with coronary artery disease. The chosen therapy, whether it is angioplasty, surgery or a combination of the two, should be determined specifically for an individual patient, Williams said.

The course also includes sessions on valvular heart disease, minimally invasive surgery, new surgical technologies, abdominal aortic endografting, aortic aneurismal disease overview and thoracic aortic endografting.

For more information: www.tctconference.com

Related Content

Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease
News | Cardiovascular Surgery | May 03, 2019
Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one...
SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Overlay Init